Dr Maja Petkovic commented “The first FDA approved treatments were CAR-T cells directed against the B cell protein CD19. This ...
A research team led by Professor Simona Giunta at the University of Rome La Sapienza has produced the first reference-quality ...
WuXi Biologics, a global CRDMO, has launched TrueSite TI, a targeted integration (TI)-based CHO cell line platform.
The reference-quality genome assembly of an experimentally relevant human cell line, retinal pigment epithelial line RPE-1, is completed.
A team led by Christian Baumgartner of the Institute of Health Care Engineering at Graz University of Technology (TU Graz) ...
TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability.The platform has achieved ...
Synthetic bio company Asimov agreed to collaborate with Cytiva to provide customers with an integrated offering for optimized biologics production. Access includes Asimov’s CHO Edge cell line ...
Cell painting has established itself as a powerful tool for high content imaging, able to generate vast quantities of data in response to chemical perturbations. Over the past decade, cell painting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback